Cargando…
A Randomized Controlled Trial of Intralesional Glucocorticoid for Treating Pretibial Myxedema
BACKGROUND: Pretibial myxedema (PTM) is an uncommon dermopathy associated with autoimmune thyroid diseases. Now it is thought to be autoimmune and its treatment with glucocorticoid is helpful. However, it has not been evaluated. METHODS: A prospective randomized controlled trial was performed in 110...
Autores principales: | Lan, Changgui, Li, Can, Chen, Wei, Mei, Xiaofeng, Zhao, Jing, Hu, Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elmer Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4596268/ https://www.ncbi.nlm.nih.gov/pubmed/26491499 http://dx.doi.org/10.14740/jocmr2303w |
Ejemplares similares
-
Pretibial myxedema successfully treated with intralesional hyaluronidase
por: Hoesly, Paul M., et al.
Publicado: (2018) -
Pretibial myxedema treated with intralesional hyaluronidase and triamcinolone
por: Kudlak, Natalie, et al.
Publicado: (2020) -
Treatment of pretibial myxedema with intralesional immunomodulating therapy
por: Ren, Ziwei, et al.
Publicado: (2017) -
Intralesional and topical glucocorticoids for pretibial myxedema: A case report and review of literature
por: Zhang, Fan, et al.
Publicado: (2018) -
A Case of Elephantiasic Pretibial Myxedema Successfully Treated With Intralesional Triamcinolone Acetate
por: Hathi, Deep, et al.
Publicado: (2022)